Sigma backer lifts the lid on its investment strategy

A major Sigma shareholder has shared further insight into its investment philosophy, as the market awaits the competition watchdog’s call on the supplier’s proposed merger with CWH HMC Capital’s Partner Fund 1 has held a high conviction position in Sigma Healthcare ahead of the planned $8.8bn reverse merger with Chemist Warehouse (CWH), which has delivered